Patients with Parkinson’s share daily strategies and patient accounts that transform how others approach living with this progressive neurological condition.
Parkinson’s disease can cause a dangerous blood pressure paradox: high pressure while lying down and dangerously low pressure when standing.
Disease-modifying therapies now drive Parkinson’s research, targeting neurodegeneration itself rather than just managing movement symptoms.
Tremors and dyskinesia are distinct involuntary movements in advanced Parkinson’s, arising from different causes and requiring separate management approaches.
After retirement and a Parkinson’s diagnosis, one patient rediscovered purpose and identity through the act of making art.
Amneal Pharmaceuticals faces documented legal challenges in 2026, but no verified lawsuit exists about challenging generic Parkinson’s medication copies.
Early Parkinson’s often hides in plain sight—subtle tremor, stiffness, and slowness that seem like normal aging until you recognize the pattern.
A major stem cell therapy trial for Parkinson’s disease has finished enrolling participants, marking a critical milestone in experimental treatment research.
Biotech collaborations are redesigning tremor medication delivery through transdermal patches, offering consistent dosing and better adherence for patients seeking alternatives to daily pills.
A father with Parkinson’s climbed Africa’s tallest peak with his daughter, defying assumptions about what the disease allows.